Evidence map›Paper›PMID 38004522›Full record

ArticlePharmaceutics2023

Effect of Phenolics from

Marwah M Alfeqy, Seham S El-Hawary, Ali M El-Halawany, Mohamed A Rabeh, Saad A Alshehri, Aya M Serry, Heba A Fahmy, Marwa I Ezzat

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Biosynthesis and Characterization ofInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Marwah M AlfeqyPharmacognosy Department, Faculty of Pharmacy, Modern University for Technology & Information, Cairo 11571, Egypt.
Seham S El-HawaryPharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini, Cairo 11562, Egypt.
Ali M El-HalawanyPharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini, Cairo 11562, Egypt.ORCID 0000-0002-5864-1674
Mohamed A RabehPharmacognosy Department, College of Pharmacy, King Khalid University, Abha 62251, Saudi Arabia.
Saad A AlshehriPharmacognosy Department, College of Pharmacy, King Khalid University, Abha 62251, Saudi Arabia.ORCID 0000-0001-6266-7116
Aya M SerryPharmaceutical Chemistry Department, Faculty of Pharmacy, Modern University for Technology & Information, Cairo 11571, Egypt.
Heba A FahmyPharmacognosy Department, Faculty of Pharmacy, Modern University for Technology & Information, Cairo 11571, Egypt.ORCID 0000-0001-7359-2447
Marwa I EzzatPharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr El Aini, Cairo 11562, Egypt.ORCID 0000-0002-7776-0265
Cairo University · EGModern University for Information and Technology · EGKing Khalid University · SA

Funding

King Khalid University RGP1/165/44Mohamed A. Rabeh,Pharmacognosy Department, College of Pharmacy, King Khalid University, Abha 62251, Saudi Arabia RGP1/165/44
6 · The paper itself

Abstract

Metabolic syndrome (MetS) is a global issue affecting over a billion people, raising the risk of diabetes, cardiovascular disorders, and other ailments. It is often characterized by hypertension, dyslipidemia and/or obesity, and hyperglycemia. Chemical investigation of

Indexed as

Aeonium arboreumantioxidantlipasemetabolic syndromeα-glucosidase

Identifiers

PMID38004522
PMCPMC10675073
OpenAlexW4387971939

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.